Evidence map›Paper›PMID 9811336›Full record

ArticleThe American journal of pathology1998

Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.

B P Rubin, C J Chen, T W Morgan, S Xiao, H E Grier, H P Kozakewich, A R Perez-Atayde, J A Fletcher

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 4 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 4 syntheses or guidelines pooled it, 441 citations in OpenAlex.

  1. Future oncology (London, England) · 2025
    Pooled it
  2. Guideline
  3. Pooled it
  4. Guideline
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. International journal of molecular sciences · 2024
    Review
  14. Review
  15. Phase separation underlies signaling activation of oncogenic NTRK fusions.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. Biomedical reports · 2023
    Article
  18. Cancers · 2023
    Article
  19. Article
  20. GISTs withCancers · 2022
    Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

B P RubinDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
C J Chen
T W Morgan
S Xiao
H E Grier
H P Kozakewich
A R Perez-Atayde
J A Fletcher
Harvard University · USDana-Farber Cancer Institute · USBoston Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Morphological, cytogenetic, and biological evidence supports a relationship between congenital (infantile) fibrosarcoma (CFS) and congenital mesoblastic nephroma (CMN). These tumors have a very similar histological appearance, and they are both associated with polysomies for chromosomes 8, 11, 17, and 20. Recently, CFS was shown to contain a novel t(12; 15)(p13;q25) translocation resulting in ETV6-NTRK3 gene fusion. The aims of this study were to determine whether congenital mesoblastic nephroma contains the t(12;15)(p13;q25) translocation and ETV6-NTRK3 gene fusion and whether ETV6-NTRK3 fusions, in CMN and CFS, antedate acquisition of nonrandom chromosome polysomies. To address these aims, we evaluated 1) ETV6-NTRK3 fusion transcripts by reverse transcriptase polymerase chain reaction and sequence analysis, 2) genomic ETV6-region chromosomal rearrangement by fluorescence in situ hybridization, and 3) chromosomal polysomies by karyotyping and fluorescence in situ hybridization. We report ETV6-NTRK3 fusion transcripts and/or ETV6-region rearrangement in five of six CMNs and in five of five CFSs. The ETV6-NTRK3 fusion transcripts and/or ETV-region chromosome rearrangements were demonstrated in two CMNs and one CFS that lacked chromosome polysomies. These findings demonstrate that t(12;15) translocation, and the associated ETV6-NTRK3 fusion, can antedate acquisition of chromosome polysomies in CMN and CFS. CMN and CFS are pathogenetically related, and it is likely that they represent a single neoplastic entity, arising in either renal or soft tissue locations.

Indexed as

Artificial Gene FusionChromosomes, Human, Pair 12Chromosomes, Human, Pair 15Repressor ProteinsDNA-Binding ProteinsETS Translocation Variant 6 ProteinFemaleFibrosarcomaGenetic MarkersHumansInfant, NewbornIn Situ Hybridization, FluorescenceKaryotypingKidney NeoplasmsMaleNephroma, MesoblasticDNA-Binding ProteinsETS Translocation Variant 6 ProteinGenetic MarkersProto-Oncogene Proteins c-etsReceptor Protein-Tyrosine KinasesReceptors, Nerve Growth FactorReceptor, trkCRepressor ProteinsTranscription Factors

Identifiers

PMID9811336
PMCPMC1853403
OpenAlexW1494352958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.